SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-20-235006
Filing Date
2020-08-31
Accepted
2020-08-28 20:52:31
Documents
12
Period of Report
2020-06-30
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K/A d141293d8ka.htm   iXBRL 8-K/A 45379
  Complete submission text file 0001193125-20-235006.txt   180084

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA myl-20200630.xsd EX-101.SCH 3057
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE myl-20200630_lab.xml EX-101.LAB 20261
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myl-20200630_pre.xml EX-101.PRE 12708
5 EXTRACTED XBRL INSTANCE DOCUMENT d141293d8ka_htm.xml XML 4053
Mailing Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL
Business Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL 44 0 1707 853 000
Mylan N.V. (Filer) CIK: 0001623613 (see all company filings)

IRS No.: 981189497 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 333-199861 | Film No.: 201149608
SIC: 2834 Pharmaceutical Preparations